Newsgather

drugs

Stabil172 Meldungen16 QuellenZuletzt aktualisiert: 9 sa önce

Neueste Meldungen

India Mandates Prescription for Cough Syrups to Curb Misuse and Contamination
In Entwicklung
Gesundheit·1 g önceKI-Zusammenfassung

India Mandates Prescription for Cough Syrups to Curb Misuse and Contamination

India's Ministry of Health and Family Welfare now requires a doctor's prescription to buy cough syrups and other syrup medicines, ending over-the-counter sales. This move aims to prevent misuse, recreational drug use, and accidental poisoning, especially among adolescents and young adults, and addresses a history of contaminated Indian-made medicines causing child deaths globally.

T
Times of India
Britain's Debate on Rejoining the EU: A Solipsistic Approach
In Entwicklung
Politik·2 g önceKI-Zusammenfassung

Britain's Debate on Rejoining the EU: A Solipsistic Approach

As the 10th anniversary of Brexit approaches, Britain debates rejoining the EU, focusing on economic benefits and political feasibility. However, the discussion largely ignores the perspectives of other European nations and the EU's own priorities, such as Ukraine and global economic challenges. While some UK politicians advocate for rejoining, the EU has other candidates and a minority who may not welcome Britain back.

G
Guardian Business
India's Growing Out-of-Pocket Healthcare Expenses: Weight-Loss Drugs, Cosmetic Procedures Excluded from Insurance
In Entwicklung
Business·2 g önceKI-Zusammenfassung

India's Growing Out-of-Pocket Healthcare Expenses: Weight-Loss Drugs, Cosmetic Procedures Excluded from Insurance

Demand for weight-loss drugs, cosmetic procedures, and wellness treatments is driving out-of-pocket healthcare spending in India. Most of these interventions, like Botox and anti-obesity drugs, are not covered by standard health insurance unless medically necessary. Experts advise reviewing policy exclusions and avoiding EMIs for elective treatments.

E
Economic Times
India's Growing Out-of-Pocket Healthcare: Weight-Loss Drugs, Cosmetic Procedures Excluded from Insurance
In Entwicklung
Business·2 g önceKI-Zusammenfassung

India's Growing Out-of-Pocket Healthcare: Weight-Loss Drugs, Cosmetic Procedures Excluded from Insurance

Demand for weight-loss drugs, cosmetic procedures, and wellness treatments is driving out-of-pocket healthcare expenses in India. Most of these, like Botox and anti-obesity drugs, are not covered by standard health insurance unless medically necessary, experts advise understanding policy exclusions and avoiding EMIs for elective treatments.

E
Economic Times
Telehealth Companies Managing Obesity Drug Costs Face Scrutiny
In Entwicklung
Gesundheit·3 g önceKI-Zusammenfassung

Telehealth Companies Managing Obesity Drug Costs Face Scrutiny

Telehealth companies hired by employers to manage obesity drug costs are facing criticism for potentially limiting patient access to medications like Zepbound and Wegovy. Patients report being forced to try generic drugs first or facing hurdles that lead to out-of-pocket expenses, while doctors express concern over these companies offering medical advice outside their scope.

N
NPR News
Hong Kong police arrest four, seize HK$7.2 million in drugs linked to online gaming recruitment
In Entwicklung
Crime·4 g önceKI-Zusammenfassung

Hong Kong police arrest four, seize HK$7.2 million in drugs linked to online gaming recruitment

Hong Kong police have arrested four men and seized HK$7.2 million (US$918,850) worth of suspected drugs, including ketamine, cocaine, and etomidate. The operation, which began Thursday, uncovered a syndicate that allegedly recruited two mainland Chinese men through online gaming platforms to help with drug packaging and distribution in the city.

S
SCMP Economy
Drug Repurposing: From Diabetes to Weight Loss and Beyond
In Entwicklung
Gesundheit·6 g önceKI-Zusammenfassung

Drug Repurposing: From Diabetes to Weight Loss and Beyond

The article explores drug repurposing, highlighting GLP-1 agonists like Ozempic and Wegovy, initially for diabetes, now used for weight loss, cardiovascular health, and more. It also discusses COVID-19 treatments like dexamethasone and baricitinib, and historical examples like raloxifene, thalidomide, BCG vaccine, and Viagra, emphasizing both the benefits and potential risks of using drugs for unapproved conditions.

D
Deutsche Welle